Emilie Naidoff, SLP - Speech-Language Pathologist in Algonquin, IL

Emilie Naidoff, SLP is a Speech-language Pathologist based in Algonquin, Illinois. Emilie Naidoff is licensed to practice in * (Not Available) (license number ) and her current practice location is 1554 E Algonquin Rd, Algonquin, Illinois. She can be reached at her office (for appointments etc.) via phone at (847) 707-6744.

NPI number for Emilie Naidoff is 1114645140 and her current mailing address is Po Box 411169, Boston, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114645140.

Contact Information

Emilie Naidoff, SLP
1554 E Algonquin Rd,
Algonquin, IL 60102-4519
(847) 707-6744
Not Available



Healthcare Provider's Profile

Full NameEmilie Naidoff
GenderFemale
SpecialitySpeech-language Pathologist
Location1554 E Algonquin Rd, Algonquin, Illinois
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1114645140
  • Provider Enumeration Date: 08/16/2022
  • Last Update Date: 08/16/2022

Medical Identifiers

Medical identifiers for Emilie Naidoff such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114645140NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist (* (Not Available))Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Emilie Naidoff is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Emilie Naidoff, SLP
Po Box 411169,
Boston, MA 02241-1169

Ph: (888) 830-4125
Emilie Naidoff, SLP
1554 E Algonquin Rd,
Algonquin, IL 60102-4519

Ph: (847) 707-6744

News Archive

Statins account for 81% of first-line therapies for dyslipidemia treatment

Decision Resources, Inc., finds that despite the dominant market position of statins in the treatment of dyslipidemia, only 81% of patients receive a statin as a first-line therapy for the disease.

New project aims to identify quantitative biological features common across diseases

Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).

RaySearch Laboratories' interim report for the period January 1 – September 30, 2009

"It is extremely satisfying that the major development efforts during recent years are now beginning to pay off. In November our new product for Philips started generating revenues and we anticipate that the total revenue contribution from this and other new products will exceed SEK 10 M already in the fourth quarter," says Johan Löf, President of RaySearch.

'No evidence' mutant bird flu virus poses increased risk to humans, WHO and FAO say

After the U.N. Food and Agriculture Organization (FAO) "last week voiced concern about the appearance in Vietnam and China of" a mutant strain of the H5N1 bird flu virus, the WHO and FAO on Monday "said in a joint statement issued in response to questions from Agence France-Presse" that "there is no evidence to suggest yet that this new virus strain will have any increased risk to human health," the news agency reports.

Study shows how wrong levels of protein linked with AD can lead to dangerous blockages in brain cells

​Scientists have known for some time that a protein called presenilin plays a role in Alzheimer's disease, and a new study reveals one intriguing way this happens.

Read more News

› Verified 2 days ago


Speech-Language Pathologist in Algonquin, IL

Christina Ostien, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2001 W Algonquin Rd, Algonquin, IL 60102
Phone: 708-228-4529    
Megan Polivka,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1554 E Algonquin Rd, Algonquin, IL 60102
Phone: 847-707-6744    
Mrs. Mary Greco, M.S., CCC-SLP/L
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 703 Surrey Ln, Algonquin, IL 60102
Phone: 847-840-9432    
Melissa Sue Aeschliman, M.S.
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 8 White Chapel Ct., Algonquin, IL 60102
Phone: 847-431-6233    
Shalynn Morgan, M.ED CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2316 Barrett Dr, Algonquin, IL 60102
Phone: 847-532-1899    
Ms. Lisa Kosi, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2324 Loop Rd, Algonquin, IL 60102
Phone: 847-323-1761    Fax: 847-841-3712

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.